-
公开(公告)号:WO2006006490A1
公开(公告)日:2006-01-19
申请号:PCT/JP2005/012569
申请日:2005-07-07
Applicant: 小野薬品工業株式会社 , 鳥巣 一彦 , 中井 義彦 , 江頭 啓 , 酒井 優
IPC: C07D487/10
CPC classification number: C07D405/14 , A61K31/444 , A61K31/4545 , C07D401/12 , C07D401/14 , C07D471/10
Abstract: A compound represented by the general formula (I) (wherein ring A represents a monocycle substituted by R
Abstract translation: 由通式(I)表示的化合物(其中环A表示被R
-
公开(公告)号:WO2007007588A1
公开(公告)日:2007-01-18
申请号:PCT/JP2006/313290
申请日:2006-07-04
Applicant: 小野薬品工業株式会社 , 鳥巣 一彦 , 酒井 優
IPC: C07D409/14 , A61K31/4245 , A61K31/454 , A61K31/5377 , A61K31/551 , A61P3/04 , A61P3/06 , A61P3/10 , A61P7/02 , A61P9/00 , A61P9/08 , A61P9/12 , A61P25/28 , A61P35/00 , A61P43/00 , C07D413/10 , C07D413/14
CPC classification number: C07D413/14 , C07D413/10 , C07D413/12
Abstract: Disclosed is a compound having aN FXa inhibitory effect, which is useful in the prevention and/or treatment of a thrombotic disease having an activated blood coagulation mechanism, such as a thrombosis/embolism associated with a cardiovascular disease, a thrombosis/embolism associated with a cerebrovascular disease and a thrombosis/embolism associated with a venous disease. A compound represented by the general formula (I), a salt or solvate of the compound or a prodrug of the compound, salt or solvate: (I) wherein the ring A represents a cyclic group having a planarity which may be substituted by a substituent; B represents a cyclic group which may be substituted by a substituent; R 1 represents a substituent; and X represents a spacer for the main chain which has 1 to 5 atoms and may be further substituted by a substituent.
Abstract translation: 公开了具有N FXa抑制作用的化合物,其可用于预防和/或治疗具有活化凝血机制的血栓形成疾病,例如与心血管疾病相关的血栓形成/栓塞,与...相关的血栓形成/栓塞 脑血管疾病和与静脉疾病相关的血栓形成/栓塞。 由通式(I)表示的化合物,化合物的盐或溶剂化物或化合物的前药,盐或溶剂化物:(I)其中环A表示具有可被取代基取代的平面性的环状基团 ; B表示可被取代基取代的环状基团; R 1表示取代基; X表示具有1〜5个原子且可以被取代基进一步取代的主链的间隔基。
-
公开(公告)号:WO2003022814A1
公开(公告)日:2003-03-20
申请号:PCT/JP2002/009078
申请日:2002-09-06
Applicant: 小野薬品工業株式会社 , 鳥巣 一彦 , 岩橋 摩紀 , 小林 馨 , 南部 文男
IPC: C07D209/26
CPC classification number: C07D405/12 , A61K31/405 , A61K31/422 , A61K31/4439 , A61K31/4709 , A61K31/538 , C07D209/22 , C07D401/12 , C07D413/12
Abstract: Indole derivatives represented by the following general formula I and salts thereof: I wherein each symbol is as defined in the description. Because of binding to a DP receptor and antagonizing the same, the compounds of the general formula I are useful in preventing/treating allergic diseases, diseases associated with itch, diseases secondarily caused by behaviors associating itch, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion injury, cerebrovascular diseases, rheumatoid arthritis-complicated pleuritis, ulcerative colitis, etc.
Abstract translation: 由以下通式I表示的吲哚衍生物及其盐:其中每个符号如说明书中所定义。 由于与DP受体结合并拮抗DP受体,因此通式I的化合物可用于预防/治疗过敏性疾病,与瘙痒相关的疾病,由与瘙痒相关的行为,炎症,慢性阻塞性肺病,缺血再灌注 损伤,脑血管疾病,类风湿关节炎复杂性胸膜炎,溃疡性结肠炎等
-
公开(公告)号:WO2003022813A1
公开(公告)日:2003-03-20
申请号:PCT/JP2002/009077
申请日:2002-09-06
Applicant: 小野薬品工業株式会社 , 鳥巣 一彦 , 長谷川 知之 , 小林 馨 , 南部 文男
IPC: C07D209/12
CPC classification number: C07D405/12 , A61K31/405 , A61K31/538 , C07D209/08 , C07D209/12 , C07D411/12 , C07D413/12
Abstract: Indole derivatives represented by the following general formula I: I wherein each symbol is as defined in the description a process for producing the same and DP receptor antagonists containing the same as the active ingredient. Because of binding to a DP receptor and antagonizing the same, the compounds of the general formula I are useful in preventing/treating allergic diseases, diseases associated with itch, diseases secondarily caused by behaviors associating itch, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion injury, cerebrovascular diseases, rheumatoid arthritis-complicated pleuritis, ulcerative colitis, etc.
Abstract translation: 由以下通式I表示的吲哚衍生物:其中每个符号如说明书中所定义,其制备方法和含有该活性成分的DP受体拮抗剂。 由于与DP受体结合并拮抗DP受体,因此通式I的化合物可用于预防/治疗过敏性疾病,与瘙痒相关的疾病,由与瘙痒相关的行为,炎症,慢性阻塞性肺病,缺血再灌注 损伤,脑血管疾病,类风湿关节炎复杂性胸膜炎,溃疡性结肠炎等
-
-
-